ondansetron has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the efficacy of 5-hydroxytryptamine type 3 receptor (5-HT-3R) antagonist (ondansetron) vs paracetamol in primary fibromyalgia (FM) syndrome." | 9.08 | Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. ( Hrycaj, P; Mennet, P; Müller, W; Stratz, T, 1996) |
| "To study the efficacy of 5-hydroxytryptamine type 3 receptor (5-HT-3R) antagonist (ondansetron) vs paracetamol in primary fibromyalgia (FM) syndrome." | 5.08 | Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. ( Hrycaj, P; Mennet, P; Müller, W; Stratz, T, 1996) |
| "After confirming hyperalgesia, male mice were treated with αTPN-βCD (25, 50 or 100 mg/kg; p." | 1.43 | α-Terpineol, a monoterpene alcohol, complexed with β-cyclodextrin exerts antihyperalgesic effect in animal model for fibromyalgia aided with docking study. ( Almeida, JR; Araújo, AA; Araújo-Filho, HG; Brito, RG; Carvalho, YM; Menezes, PP; Oliveira, MG; Quintans, JS; Quintans-Júnior, LJ; Santos, PL; Scotti, L; Scotti, MT; Serafini, MR; Shanmugam, S; Silva, JC; Thangaraj, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, MG | 1 |
| Brito, RG | 1 |
| Santos, PL | 1 |
| Araújo-Filho, HG | 1 |
| Quintans, JS | 1 |
| Menezes, PP | 1 |
| Serafini, MR | 1 |
| Carvalho, YM | 1 |
| Silva, JC | 1 |
| Almeida, JR | 1 |
| Scotti, L | 1 |
| Scotti, MT | 1 |
| Shanmugam, S | 1 |
| Thangaraj, P | 1 |
| Araújo, AA | 1 |
| Quintans-Júnior, LJ | 1 |
| Hrycaj, P | 1 |
| Stratz, T | 1 |
| Mennet, P | 1 |
| Müller, W | 1 |
1 trial available for ondansetron and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.
Topics: Acetaminophen; Adult; Cross-Over Studies; Double-Blind Method; Female; Fibromyalgia; Humans; Male; M | 1996 |
1 other study available for ondansetron and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
α-Terpineol, a monoterpene alcohol, complexed with β-cyclodextrin exerts antihyperalgesic effect in animal model for fibromyalgia aided with docking study.
Topics: Analgesics; Animals; Behavior, Animal; beta-Cyclodextrins; Binding Sites; Cyclohexane Monoterpenes; | 2016 |